Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oléogrape SEED (branded as 'grape + olive') is a natural polyphenol extract derived from olive and grape seeds, developed by Grap'Sud Union and studied clinically by Nantes University Hospital. It is standardized to contain specific levels of hydroxytyrosol (from olive) and procyanidins (from grape seed). The product is investigated as a nutraceutical for the treatment of knee osteoarthritis, where it aims to reduce joint inflammation and protect cartilage. Its primary mechanism of action is the modulation of inflammatory pathways, specifically through the inhibition of inflammatory mediators such as interleukin-1 beta (IL-1β).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Oléogrape SEED.